Wild type Cas9 mRNA (N1-Me-Pseudo UTP) allows for the expression of a Streptococcus pyogenes SF370 Cas9 protein (CRISPR-associated protein 9), which is part of the CRISPR genome editing system, when transfected into cells. In the CRISPR system, when co-transfected with guide RNA (gRNA) targeting specific genomic loci, the Cas9 protein can cleave the targeted genes under the guidance of the gRNA.
• Used for CRISPR/Cas9-mediated gene editing.
• Sequence optimized and selected for high expression.
• Oligo-dT purification ensures high quality and purity.
• Carefully controlled processes to minimize batch-to-batch variation.
4462nt
2 mg/mL
Below -65℃
Dry ice
Visual
USP<791>
UV
UV
HPLC
CE
LC-MS
LC-MS
Nano Orange
ELISA
qPCR
Gel-clot method

Figure 1. In vivo editing efficiency in mouse liver after IV injection of Cas9 mRNA lipid nanoparticles (LNP).

Figure 2. T7 Endonuclease I digestion in 293T cell to verify Cas9 mRNA editing efficiency after cell transfection.

Figure 3. mRNA cell-free translation results by SDS-page.